Kategorie: Aggressive Lymphome
Leiter: Herr Univ. Prof. Dr. med. Georg Heß
EudraCT-Nr.: 2019-002373-59
Rekrutierung beginnt in Kürze
A prospective, multicenter randomized phase II trial investigating Gemcitabine/Oxaliplatin/Rituximab with or without Mor208 for patients with relapsed/refractory aggressive lymphoma